Goodwin Bradford S 4
4 · NeurogesX Inc · Filed Feb 1, 2012
Insider Transaction Report
Form 4
NeurogesX IncNGSX
Goodwin Bradford S
Director
Transactions
- Award
Common Stock
2012-01-31$1.01/sh+20,000$20,200→ 95,000 total(indirect: See footnote)
Footnotes (4)
- [F1]The securities sold in the private placement have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from the registration requirements. NeurogesX has agreed to file a registration statement with the Commission covering the resale of the shares of common stock sold in the private placement.
- [F2]The purchase price per shares is $1.01, and is based on the consolidated closing bid price of NGSX common stock on the NASDAQ Global Market on January 31, 2012.
- [F3]Bradford S. Goodwin, as trustee of the Goodwin Family Trust, u/a/d 7/30/97 indirectly holds 80,000 shares of common stock and Bradford S. Goodwin directly owns 15,000 shares of common stock.
- [F4]These shares are held indirectly by Bradford S. Goodwin, as trustee of the Goodwin Family Trust, u/a/d 7/30/97.